ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026

Pivotal posters at ASBrS 2026 highlight body composition monitoring, BIS, and lymphedema surveillance in breast cancer care CARLSBAD, Calif., May 1, 2026 /PRNewswire/ — ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, today…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks